Dr. Jordan Mark Reader, DO

Dr. Reader practices at Nipomo Health Center in Nipomo, California.

Dr. Reader's NPI, 1770146862, was assigned on April 15, 2019. Dr. Reader graduated from University of New England, College of Osteo Medicine in 2019. Dr. Reader holds California license 20A20095.

Dr. Reader's primary practice is Nipomo Health Center, at 697 W Tefft St, Nipomo, CA 93444-9190. The practice phone is (802) 929-2272.

Dr. Reader's primary practice is Nipomo Health Center in Nipomo, California. Dr. Reader is also affiliated with Dignity Health - Marian Regional Medical Center. The medical group on file is Pacific Central Coast Health Centers Medical Group. Dmand AI also links Dr. Reader to 1 more hospital and 3 home health agencies, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reader practices, 6 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Reader's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Reader is board certified in family medicine by the American Board of Family Medicine. Dr. Reader is licensed in California.

Dmand AI lists acid reflux, acute gastroduodenitis, acute kidney failure, acute skin infection, aneurysm, anxiety, arthritis and asthma among the conditions Dr. Reader treats.

CMS data shows 1,943 Medicare services from Dr. Reader across 19 procedure codes in 2024, for 432 Medicare patients. Medicare paid $180,010 for them. Every service was in an office.

CMS counts 432 Medicare patients who saw Dr. Reader in 2024. The largest group is 65 to 74, with 227 patients. 75% of them have high cholesterol, and 60% have high blood pressure. 5% are also on Medicaid. Their average risk score is 0.92, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Reader's median patient age at 70, with 57% women.

In 2024, Dr. Reader wrote 5,320 Medicare Part D claims for 484 patients. 87% of them were for generic drugs. CMS names the drug for 4,717 of them, across 106 drugs with 11 or more claims each, at $490,935 in total drug cost. In 2023, CMS named 2,138 claims across 71 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Reader for performance year 2024, reported through an alternative payment model (APM). Dr. Reader accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 28 procedures of removal of skin lesions by Dr. Reader, more than 68% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Reader in 2015. Dr. Reader's most frequent co-author is Matthew John Steinhaus.

CMS Open Payments shows 45 general payments to Dr. Reader from 16 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $140.

Dr. Reader graduated from University of New England, College of Osteo Medicine in 2019.

Dr. Reader is in network with 14 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.